CymaBay Therapeutics, Inc. Shares of Common Stock (par value $0.0001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • July 2nd, 2020 • CymaBay Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 2nd, 2020 Company Industry JurisdictionCymaBay Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows: